Bioassays of aldrin and dieldrin for possible carcinogenicity / Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health. ; prepared at Tracor Jitco, inc.

Other author Carcinogenesis Program (National Cancer Institute (U.S.)). Carcinogen Bioassay and Program Resources Branch.
Other author Tracor Jitco, Inc.
Format Electronic
Publication InfoBethesda, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1977.
Description1 online resource (xvi, 184 pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo23878
Subjects

Variant title Aldrin and dieldrin
SeriesDHEW publication ; no. (NIH) 78-821
Carcinogenesis technical report series ; no. 21
DHEW publication no. (NIH) 78-821. ^A204
National Cancer Institute carcinogenesis technical report series ; no. 21. ^A1107162
General noteTitle from title screen (viewed on June 13, 2012).
General note"CAS No's. 309-00-2 and 60-57-1."
General note"NCI-CG-TR-21."
Bibliography noteIncludes bibliographical references (p. 61-63).
Issued in other formPrint version: National Cancer Institute (U.S.). Carcinogen Bioassay and Program Resources Branch. Bioassays of aldrin and dieldrin for possible carcinogenicity
Technical rpt#CAS No. 309-00-2
Technical rpt#CAS No. 60-57-1
Technical rpt numberNCI-CG-TR-21
GPO item number0507-G-12 (online)
Govt. docs number HE 20.3159/2:21

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available